| Financial Year |
March 31 2023 |
| Monetary Funds |
80,474,084.27 |
| Held-for-trading Financial Assets |
1,049,916,654.11 |
| Notes Receivable |
-- |
| Accounts Receivable |
12,634,275.45 |
| Advances to Suppliers |
6,220,869.59 |
| Other Receivables |
4,167,859.06 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
6,450.03 |
| Dividend Receivable |
-- |
| Inventories |
19,387,492.43 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,599,999.42 |
| Total Current Assets |
1,176,321,733.77 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
775,950,960.00 |
| Fixed Assetes |
3,140,912.91 |
| Under-construction Projects |
335,371.06 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
267,775.14 |
| R&D expenses |
-- |
| Goodwill |
82,042,562.66 |
| Long-Term Deferred and Prepaid Expenses |
671,671.54 |
| Deferred Income Tax Assets |
277,799.48 |
| Other Non-Current Assets |
4,207,969.97 |
| Sub-Total of Non-Current Assets |
881,780,047.74 |
| Total Assets |
2,058,101,781.51 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
5,704,778.21 |
| Accounts Received In Advance |
6,068,879.63 |
| Employee Compensation Payable |
12,712,549.33 |
| Taxes Payable |
9,699,785.01 |
| Interest Payable |
-- |
| Dividend Payable |
2,534,230.18 |
| Other payables |
34,548,098.83 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
793,749.23 |
| Other Current Liabilities |
760,268.19 |
| Sub-Total of Current Liabilities |
95,022,576.32 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
7,972,790.14 |
| Deferred Income Tax Liabilities |
179,665,323.22 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
187,930,994.11 |
| Total Liabilities |
282,953,570.43 |
| Paid-In Capital(Or Share Stock) |
586,656,002.00 |
| Capital Surplus |
-- |
| Surplus Reserve |
169,030,157.22 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
672,811,022.13 |
| Minority Stockholder's Interest |
18,870,383.74 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,756,277,827.34 |
| Owner's Equity（Stockholder's Equity） |
1,775,148,211.08 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,058,101,781.51 |
